Cheng Simon K, Olale Felix, Brivanlou Ali H, Schier Alexander F
Developmental Genetics Program, Skirball Institute of Biomolecular Medicine, and Department of Cell Biology, New York University School of Medicine, New York, USA.
PLoS Biol. 2004 Feb;2(2):E30. doi: 10.1371/journal.pbio.0020030. Epub 2004 Feb 17.
Members of the EGF-CFC family play essential roles in embryonic development and have been implicated in tumorigenesis. The TGFbeta signals Nodal and Vg1/GDF1, but not Activin, require EGF-CFC coreceptors to activate Activin receptors. We report that the TGFbeta signaling antagonist Lefty also acts through an EGF-CFC-dependent mechanism. Lefty inhibits Nodal and Vg1 signaling, but not Activin signaling. Lefty genetically interacts with EGF-CFC proteins and competes with Nodal for binding to these coreceptors. Chimeras between Activin and Nodal or Vg1 identify a 14 amino acid region that confers independence from EGF-CFC coreceptors and resistance to Lefty. These results indicate that coreceptors are targets for both TGFbeta agonists and antagonists and suggest that subtle sequence variations in TGFbeta signals result in greater ligand diversity.
表皮生长因子 - CFC 家族成员在胚胎发育中发挥着重要作用,并且与肿瘤发生有关。转化生长因子β(TGFβ)信号通路中的 Nodal 和 Vg1/GDF1,但不包括激活素(Activin),需要表皮生长因子 - CFC 共受体来激活激活素受体。我们报告称,转化生长因子β信号拮抗剂 Left 也通过一种依赖表皮生长因子 - CFC 的机制发挥作用。Left 抑制 Nodal 和 Vg1 信号,但不抑制激活素信号。Left 在基因上与表皮生长因子 - CFC 蛋白相互作用,并与 Nodal 竞争结合这些共受体。激活素与 Nodal 或 Vg1 之间的嵌合体确定了一个 14 个氨基酸的区域,该区域赋予了不依赖表皮生长因子 - CFC 共受体以及对 Left 的抗性。这些结果表明,共受体是转化生长因子β激动剂和拮抗剂的作用靶点,并表明转化生长因子β信号中的细微序列变异导致了更大的配体多样性。